White House Affirms EPA’s ‘Sole Authority’ on Endocrine Program Decisions

White House Office of Management and Budget director Peter Orzag says OMB supports EPA’s sole authority to make scientific decisions for the endocrine disruptor screening program (EDSP), and that OMB’s recent comments in an approval of the agency’s data collection requests were not a ruling on the adequacy of existing toxicological data. At issue is a reference made by OMB in its approval of EPA’s data collection orders under EDSP program. OMB stated that EPA should, “to the greatest extent possible,” allow the use existing...

If you have already signed up for access to Chemical Week Regulatory Watch, please log in here.

Forgot your user ID or password?
Click here to have it sent to you.